CANCER CELL

简称 CANCER CELL ·UNITED STATES ·出版周期 Monthly ·年均收录 121 篇

44.5

最新影响因子

2.30%

自引率

极难

投稿难度

偏慢,4-8周

审稿周期

期刊简介

CANCER CELL是一本国际知名的肿瘤学研究期刊，ISSN号为1535-6108，由Cell Press出版社出版，出版地为美国，出版周期为月刊。该期刊的影响因子较高，在肿瘤学领域具有重要影响力，属于SCI收录期刊，并且在中科院分区中通常位列一区或二区。CANCER CELL并非完全开放获取（OA）期刊，但提供部分开放获取选项。该期刊的发文特点主要集中在肿瘤生物学、癌症机制、治疗靶点及临床转化研究等领域，尤其关注创新性和高影响力的基础与临床研究。杂志的质量较高，审稿严格，发表的研究通常具有重要科学价值，但投稿竞争激烈，拒稿率较高，对研究新颖性和数据完整性要求极高，因此投稿存在一定风险。

影响因子趋势

近期发表

Tumor evolution shapes metastatic competence in colorectal cancer 2026-09-01

TIME in motion: How response takes shape 2026-09-01

Retraction Notice to: Taxanes trigger cancer cell killing in vivo by inducing non-canonical T cell cytotoxicity 2026-09-05

Integrated clinicogenomic analysis reveals the evolution and metastatic tropisms of advanced colorectal cancer 2026-09-01

Tumor immune microenvironment remodeling predicts response to checkpoint inhibitor therapy 2026-09-01

Menin in normal and malignant megakaryopoiesis 2026-07-09

Defining UHRF1 Domains that Support Maintenance of Human Colon Cancer DNA Methylation and Oncogenic Properties 2026-07-17

PD-1 blockade unleashes local hepatitis B virus-related B cell response inhibiting hepatocellular carcinoma 2026-07-16

Tumor cells recruit macrophage bodyguards to outlast chemotherapy 2026-08-20

Bile Acid and Inflammation Activate Gastric Cardia Stem Cells in a Mouse Model of Barrett-Like Metaplasia 2026-07-17